Glutathione-sensitive PEGylated curcumin prodrug nanomicelles: Preparation, characterization, cellular uptake and bioavailability evaluation
Open Access
- 1 January 2019
- journal article
- research article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 555, 270-279
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81373371)
- China Postdoctoral Science Foundation (2018M630533)
This publication has 34 references indexed in Scilit:
- Enteric Polymer Based on pH-Responsive Aliphatic Polycarbonate Functionalized with Vitamin E To Facilitate Oral Delivery of TacrolimusBiomacromolecules, 2015
- Curcumin nanoformulations: A review of pharmaceutical properties and preclinical studies and clinical data related to cancer treatmentBiomaterials, 2014
- Self-Assembling Doxorubicin–Tocopherol Succinate Prodrug as a New Drug Delivery System: Synthesis, Characterization, and in Vitro and in Vivo Anticancer ActivityBioconjugate Chemistry, 2013
- Curcumin-loaded solid lipid nanoparticles have prolonged in vitro antitumour activity, cellular uptake and improved in vivo bioavailabilityColloids and Surfaces B: Biointerfaces, 2013
- The pharmacology of curcumin: is it the degradation products?Trends in Molecular Medicine, 2012
- Time-dependent analysis of predisposing factors for the recurrence of hepatocellular carcinomaLiver International, 2009
- Curcumin and cancer: An “old-age” disease with an “age-old” solutionCancer Letters, 2008
- Hepatocellular Carcinoma: Epidemiology and Molecular CarcinogenesisGastroenterology, 2007
- Glutathione in Cancer Biology and TherapyCritical Reviews in Clinical Laboratory Sciences, 2006
- Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing miceJournal of Controlled Release, 2004